Rabbit Recombinant Monoclonal EPS15R antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
IP | Flow Cyt | WB | IHC-P | ICC/IF | |
---|---|---|---|---|---|
Human | Not recommended | Not recommended | Tested | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Predicted | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Predicted | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/10000 - 1/20000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Select an associated product type
Seems to be a constitutive component of clathrin-coated pits that is required for receptor-mediated endocytosis. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2.
EPS15R, EPS15L1, Epidermal growth factor receptor substrate 15-like 1, Eps15-related protein, Eps15R
Rabbit Recombinant Monoclonal EPS15R antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
pH: 7.2 - 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
EPS15R also known as Epidermal Growth Factor Receptor Pathway Substrate 15-Related Protein is a protein with a molecular mass of approximately 110 kDa. It acts mechanically as an adaptor protein playing significant roles in processes like endocytosis and cellular signaling. EPS15R contains several Epsin N-terminal Homology (ENTH) domains which allow it to interact with components of the clathrin-coated pits during vesicle formation. It is expressed broadly in human tissues with significant presence in the brain heart and skeletal muscles which hints at its varied functional roles.
EPS15R participates in endocytosis where it influences the internalization of receptors and other molecules into cells. It forms part of a larger protein complex involved in cargo selection and vesicle budding often associating with proteins like epsin and clathrin. This interaction facilitates the concentration and packaging of signaling receptors therefore modulating signal transduction within the cell. EPS15R's role as an adaptor enables tight regulation of receptor trafficking ensuring coordinated cellular responses to external cues.
EPS15R operates within the endocytic and ubiquitin-proteasome pathways where it modulates receptor-mediated endocytosis linked to signal transduction. In the endocytic pathway EPS15R interacts with proteins such as EGFR (Epidermal Growth Factor Receptor) helping to regulate EGFR internalization and degradation. This regulation is important for maintaining cellular homeostasis as it modulates the intensity and duration of signaling. EPS15R also associates with the ubiquitin-proteasome system through interactions with ubiquitin ligases which mark proteins for degradation and affect various signaling pathways.
EPS15R's dysregulation can contribute to neurodegenerative diseases and cancer. Altered endocytic trafficking due to EPS15R malfunction might play a role in diseases like Alzheimer's where defective protein clearance is observed. In cancer EPS15R's interactions with proteins like EGFR have implications in tumorigenesis as abnormal EGFR signaling due to misregulation at the endocytic level can promote unchecked cell proliferation. These associations emphasize EPS15R's potential as a therapeutic target for such diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
There are three isoforms with MW at 125, 108 and 76 kDa respectively.
All lanes: Western blot - Anti-EPS15R antibody [EP1146Y] (ab76004) at 1/20000 dilution
Lane 1: HeLa cell lysates at 10 µg
Lane 2: 293T cell lysates at 10 µg
Lane 3: SHSY5Y cell lysates at 10 µg
All lanes: goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 94 kDa
Observed band size: 108 kDa, 125 kDa, 76 kDa
Image collected and cropped by CiteAb under a CC-BY license from the publication
EPS15R western blot using anti-EPS15R antibody [EP1146Y] ab76004. Publication image and figure legend from Łyszkiewicz, M., Zietara, N., et al., 2020, Nat Commun, PubMed 32098969.
ab76004 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab76004 please see the product overview.
Patient-associated mutations alter either binding properties or subcellular localisation of the FCHO1 protein.a Whole-cell lysates from HEK293T cells overexpressing either wt or indicated mutant GFP-FCHO1 fusion proteins were used for immunoprecipitation. Specific bands are indicated with arrows. Anti-FCHO1 or anti-GFP antibodies were used independently to detect FCHO1-specific bands. Representative data of three independent experiments are shown. Uncropped blots are shown in Supplementary Fig. 4. b–d FCHO1-deficient SK-MEL-2 cells expressing RFP-tagged clathrin light chain from endogenous locus (CLTARFP/wt) were transiently transfected with either wt or mutated GFP-FCHO1 and fixed 24 to 36 h post transfection. Representative confocal microscopy pictures show that the F-BAR-domain-associated mutation p.A34P alters the subcellular localisation of FCHO1 and leads to the formation of large aggregates dissociated from the plasma membrane. The µHD domain-associated mutations (p.R679P and p.Stop687) abolish the interaction of FCHO1 with its interacting partners EPS15, and adaptin. All mutations obliterate interaction with endogenous clathrin. Enlarged and colour-separated regions corresponding to boxed areas are shown below each main picture. In d arrows indicate presumptive interaction of clathrin with wild-type FCHO1 and lack of such interaction for all tested mutants. Scale bar represents 5 µm for main pictures and 10 µm for enlarged regions. Colour code: b–d GFP-FCHO1, green; DAPI, blue, b EPS15, c adaptin, d clathrin–red. e Quantification of data shown in b to d. Pearson correlation or co-localisation coefficients of FCHO1 wild-type and all tested mutants with EPS15, adaptin and clathrin. Pooled data of two to three independent experiments are depicted. Each symbol represents one region of 25 µm2. Up to three regions per cells were quantified. Horizontal lines indicate the median, whiskers indicate the range (min to max). Statistical analysis of significance was performed using one-way ANOVA test followed by Tukey’s multiple comparison test to assess differences between groups. Source data are provided as a Source Data file.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com